This topic contains a solution. Click here to go to the answer

Author Question: A student's physical ability is the primary consideration during an assistive technology (AT) ... (Read 93 times)

AEWBW

  • Hero Member
  • *****
  • Posts: 579
A student's physical ability is the primary consideration during an assistive technology (AT) evaluation.
 
  Indicate whether the statement is true or false

Question 2

Autism diagnoses are decreasing.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaikhs

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

False
Explanation: The student's general cognitive ability should be considered so that developmentally appropriate techniques and AT devices are employed.

Answer to Question 2

False
Explanation: Autism diagnoses are on the rise




AEWBW

  • Member
  • Posts: 579
Reply 2 on: Jun 20, 2018
:D TYSM


tkempin

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library